madeline desogestrel 150 microgram and ethinylestradiol 30 microgram tablet blister pack
arrotex pharmaceuticals pty ltd - desogestrel, quantity: 150 microgram; ethinylestradiol, quantity: 30 microgram - tablet - excipient ingredients: povidone; titanium dioxide; magnesium stearate; maize starch; hypromellose; polysorbate 80; triacetin; indigo carmine aluminium lake; colloidal anhydrous silica; iron oxide yellow; lactose monohydrate - oral contraception
marvelon desogestrel / ethinylestradiol 28 tablets
organon pharma pty ltd - desogestrel, quantity: 150 microgram; ethinylestradiol, quantity: 30 microgram - tablet - excipient ingredients: magnesium stearate; lactose monohydrate; potato starch - oral contraception.
desogestrel/ethinylestradiol actavis 150/20 microgram film coated tablet
actavis group ptc ehf - desogestrel micronized, ethinylestradiol micronized - film coated tablet - 150/20 microgram - progestogens and estrogens, fixed combinations
desogestrel and ethinyl estradiol- desogestrel and ethinyl estradiol
mylan pharmaceuticals inc. - desogestrel (unii: 81k9v7m3a3) (desogestrel - unii:81k9v7m3a3), ethinyl estradiol (unii: 423d2t571u) (ethinyl estradiol - unii:423d2t571u) - desogestrel 0.15 mg - desogestrel and ethinyl estradiol tablets usp, 0.15 mg/0.03 mg are indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception. oral contraceptives are highly effective. table 1 lists the typical accidental pregnancy rates for users of combined oral contraceptives and other methods of contraception. the efficacy of these contraceptive methods, except sterilization, the iud, and the norplant system depends upon the reliability with which they are used. correct and consistent use of these methods can result in lower failure rates. in a clinical trial with desogestrel and ethinyl estradiol tablets, 1,195 subjects completed 11,656 cycles and a total of 10 pregnancies were reported. this represents an overall user-efficacy (typical user-efficacy) pregnancy rate of 1.12 per 100 women-years. this rate includes patients who did not take the drug correctly. table 1: percentage of women experiencing an unintended pregnancy during the first year of typical use an
ethinylestradiol / drospirenone leon farma & placebo 0.02 mg/ 3 mg film-coated tablets
laboratorios leon farma, s.a. - drospirenone; ethinylestradiol - film-coated tablet - 0.02 mg/3 milligram(s) - progestogens and estrogens, fixed combinations; drospirenone and ethinylestradiol
ethinylestradiol / drospirenone leon farma & placebo 0.03 mg/ 3 mg film-coated tablets
laboratorios leon farma, s.a. - drospirenone; ethinylestradiol - film-coated tablet - 0.03 mg/3 milligram(s) - progestogens and estrogens, fixed combinations; drospirenone and ethinylestradiol
mercilon tablets 150mcg/20mcg
merck sharp & dohme b.v. waarderweg 39, haarlem noord-holland, 2031 bn, netherlands - desogestrel, ethinylestradiol - tablet - desogestrel 150 microgram(s) ; ethinylestradiol 20 microgram(s) - sex hormones and modulators of the genital system
marviol 150/30 microgram tablets
merck sharp & dohme ireland (human health) limited - desogestrel; ethinylestradiol - tablet - 150 microgram/30 microgram(s) - progestogens and estrogens, fixed combinations; desogestrel and ethinylestradiol
marviol 150/30 microgram tablets
organon pharma (ireland) limited - desogestrel; ethinylestradiol - tablet - 150 microgram/30 microgram(s) - progestogens and estrogens, fixed combinations; desogestrel and ethinylestradiol
linessa 28 tablet
aspen pharmacare canada inc. - desogestrel; ethinyl estradiol; desogestrel; ethinyl estradiol; desogestrel; ethinyl estradiol - tablet - 0.1mg; 0.025mg; 0.125mg; 0.025mg; 0.15mg; 0.025mg - desogestrel 0.1mg; ethinyl estradiol 0.025mg; desogestrel 0.125mg; ethinyl estradiol 0.025mg; desogestrel 0.15mg; ethinyl estradiol 0.025mg - contraceptives